
In a new podcast episode, Thomas Hope, MD, shares his insights on glioma imaging and the potential impact of the recently FDA-approved PET agent floretyrosine (18F-FET),
Case History: 45-year-old male with history of alcoholism with history of four seizures one day earlier.
Case History: A 45-year-old male with history of alcoholism presents to emergency department with history of four seizures one day earlier.





